Meet the Team CEO and Founder Spencer Nadolsky, DO, ABOM, ABCL Spencer Nadolsky, DO, ABOM, ABCL CEO and Founder Dr
Our integrated approach, combining advanced mass spectrometry, enzymatic digestion strategies, and NMR spectroscopy, ensures thorough characterization of peptide therapeutics. For detailed information on our peptide sequencing services, visit our Peptide Sequencing Service Page
130,140 Nevertheless, it is not FDA-approved for this use
The initial question posed by this post is one we're asked very frequently
Its a risk thats simply not worth taking when safe alternatives are available